HEPARIN SODIUM INJECTION USP
HEPARIN SODIUM INJECTION USP
Discontinued
DIN Number
02382318
Drug Class
Human
Market Date
N/A
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02382318
AIG Number0104596008
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B01AB01 HEPARIN
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
,
Intravenous
AHFS Classification20:12.04.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
HEPARIN SODIUMActive
Strength: 5000 UNIT / ML
Monograph: HEPARIN SODIUM